Valuation: Integra LifeSciences Holdings Corporation

Market Cap 135.83Cr 119.14Cr 109.99Cr 101.64Cr 192.65Cr 13TCr 196.51Cr 1.32TCr 513.78Cr 6.36TCr 510.1Cr 498.92Cr 22TCr P/E 2026 *
26.9x
P/E 2027 * 14.6x
Enterprise Value 269.67Cr 236.53Cr 218.37Cr 201.79Cr 382.47Cr 26TCr 390.13Cr 2.63TCr 1.02TCr 13TCr 1.01TCr 990.49Cr 44TCr EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.46x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week-3.16%
Current month-3.54%
1 month+2.27%
3 months+80.09%
6 months+25.00%
Current year+39.49%
1 week 17.1
Extreme 17.1
18.75
1 month 16.75
Extreme 16.75
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Free

Executive/Senior Manager

11,180 0.0144%
01/07Tax

Controller/Auditor

-937 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-3.16%+33.27%-57.48% 135.83Cr
-0.91%+3.51%-28.45%-10.84% 17TCr
-2.09%+3.74%-7.25%-4.96% 11TCr
+1.34%+6.94%+3.49%+59.95% 5.92TCr
-6.77%-7.86%+44.51%+46.55% 5.3TCr
-3.47%-1.44%-13.70%-41.49% 4.31TCr
-6.00%-2.90% - - 3.64TCr
+0.39%+7.13%-11.93%-43.52% 2.84TCr
-0.56%-3.24%+60.19%-6.39% 2.52TCr
-2.04%+1.90%-7.08%+5.37% 2.12TCr
Average -2.16%+4.12%+8.12%-5.87% 5.42TCr
Weighted average by Cap. -2.00%+5.23%-4.91%+1.05%

Financials

2026 *2027 *
Net sales 167.58Cr 146.98Cr 135.7Cr 125.4Cr 237.67Cr 16TCr 242.43Cr 1.63TCr 633.84Cr 7.85TCr 629.3Cr 615.51Cr 27TCr 173.17Cr 151.89Cr 140.22Cr 129.58Cr 245.61Cr 17TCr 250.52Cr 1.69TCr 654.99Cr 8.11TCr 650.3Cr 636.04Cr 28TCr
Net income 4.27Cr 3.75Cr 3.46Cr 3.2Cr 6.06Cr 409.17Cr 6.18Cr 42Cr 16Cr 200.23Cr 16Cr 16Cr 695.08Cr 7.46Cr 6.54Cr 6.04Cr 5.58Cr 11Cr 713.97Cr 11Cr 73Cr 28Cr 349.39Cr 28Cr 27Cr 1.21TCr
Net Debt 133.83Cr 117.39Cr 108.37Cr 100.15Cr 189.82Cr 13TCr 193.62Cr 1.3TCr 506.21Cr 6.27TCr 502.59Cr 491.57Cr 22TCr 117.59Cr 103.14Cr 95Cr 88Cr 166.78Cr 11TCr 170.12Cr 1.14TCr 444.78Cr 5.51TCr 441.6Cr 431.92Cr 19TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
09/26/09 $17.33 -0.77% 3,90,076
07/26/07 $17.46 -3.96% 11,06,193
06/26/06 $18.18 +0.72% 8,82,014
02/26/02 $18.05 +0.89% 6,83,034
01/26/01 $17.89 -0.39% 8,04,611
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
17.46USD
Average target price
17.43USD
Spread / Average Target
-0.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock